Laurion Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,447
Closed -$1.31M 698
2020
Q3
$1.31M Buy
+11,447
New +$1.35M 0.02% 364
2020
Q2
Sell
-31,547
Closed -$2.53M 961
2020
Q1
$2.53M Buy
+31,547
New +$3.27M 0.03% 323
2019
Q4
Sell
-17,977
Closed -$1.92M 958
2019
Q3
$1.92M Buy
+17,977
New +$1.85M 0.01% 499
2019
Q1
Sell
-4,425
Closed -$368K 940
2018
Q4
$368K Buy
+4,425
New +$415K 0.01% 756
2018
Q3
Sell
-3,200
Closed -$352K 1249
2018
Q2
$352K Sell
3,200
-12,928
-80% -$1.35M ﹤0.01% 1052
2018
Q1
$1.62M Buy
+16,128
New +$1.65M 0.01% 699
2017
Q4
Sell
-73,600
Closed -$6.89M 1593
2017
Q3
$6.89M Buy
73,600
+29,100
+65% +$3.09M 0.03% 413
2017
Q2
$4.95M Buy
44,500
+36,800
+478% +$3.89M 0.03% 507
2017
Q1
$756K Buy
+7,700
New +$734K 0.01% 809
2016
Q2
Sell
-4,100
Closed -$293K 863
2016
Q1
$293K Buy
+4,100
New +$275K ﹤0.01% 603
2015
Q4
Sell
-7,800
Closed -$479K 915
2015
Q3
$479K Buy
+7,800
New +$545K 0.01% 448

Other funds holding DGX

Laurion Capital Management's DGX Position: Q4 2020 in Review

Laurion Capital Management sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 11,447 shares — an estimated $1.31M sold.

Laurion Capital Management first reported a position in DGX in Q3 2015 and held it in 11 quarters. The position peaked at $6.89M in Q3 2017. 811 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

  • Laurion Capital Management reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
  • Laurion Capital Management sold 11,447 Quest Diagnostics shares in Q4 2020, an estimated $1.31M.
  • Laurion Capital Management first reported a position in Quest Diagnostics in Q3 2015 and held it in 11 quarters.
  • Laurion Capital Management's Quest Diagnostics position peaked at $6.89M in Q3 2017.
  • 811 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on Laurion Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.